Impact of Aspirin on Warfarin Control as Measured by Time in Therapeutic Range

Basic Clin Pharmacol Toxicol. 2018 Oct;123(4):504-508. doi: 10.1111/bcpt.13037. Epub 2018 Jun 13.

Authors

Michelle L Boyce^{1

2}, Alexa Zayac^{1

2}, Arie Davis¹, Tony Badrick³, Shailendra Anoopkumar-Dukie¹, Nijole Bernaitis¹

Affiliations

¹ School of Pharmacy & Pharmacology and Quality Use of Medicines Network, Griffith University, Gold Coast, Qld, Australia.
² School of Pharmacy, University of Manitoba, Winnipeg, MB, Canada.
³ RCPA Quality Assurance Programs, St. Leonards, NSW, Australia.

PMID: 29753312
DOI: 10.1111/bcpt.13037

No abstract available

MeSH terms

Aged
Aged, 80 and over
Anti-Inflammatory Agents, Non-Steroidal / administration & dosage
Anticoagulants / adverse effects*
Anticoagulants / therapeutic use
Aspirin / administration & dosage*
Drug Interactions
Female
Hemorrhage / chemically induced
Hemorrhage / prevention & control
Humans
International Normalized Ratio*
Male
Middle Aged
Platelet Aggregation Inhibitors / administration & dosage
Retrospective Studies
Treatment Outcome
Warfarin / administration & dosage*

Substances

Anti-Inflammatory Agents, Non-Steroidal
Anticoagulants
Platelet Aggregation Inhibitors
Warfarin
Aspirin